ClinicalTrials.Veeva

Menu

Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

H

Hisar Intercontinental Hospital

Status

Completed

Conditions

Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

Treatments

Procedure: Injection of onabotulinumtoxinA into the bladder wall

Study type

Observational

Funder types

Other

Identifiers

NCT06408051
10.11.203/23-54

Details and patient eligibility

About

This study aimed to assess the efficacy and safety of onabotulinumtoxinA (botulinum toxin type A) in patients with idiopathic overactive bladder (OAB) and urinary incontinence who had previously failed to respond to anticholinergic treatment. Additionally, we examined the impact of significant reductions in bladder wall thickness on therapeutic outcomes.

Full description

The efficacy of OnabotulinumtoxinA was investigated in patients who attended urology outpatient clinics between January 2016 and June 2022 for overactive bladder unresponsive to anticholinergic therapy. Baseline symptoms and quality of life data were compared to those at month 6 after the treatment. The voiding diary (for 3 days) of each patient was reviewed to assess and record patients' symptoms. Baseline ultrasound (US)-measured post-void residual urine (PVR) and bladder wall thickness (BWT) values were recorded. Patients with a history of neurological disorders, anticholinergic-naive patients, patients diagnosed with bladder cancer, and those with bladder outlet obstruction were excluded from the study.

Enrollment

60 patients

Sex

All

Ages

16 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • overactive bladder urge incontinence

Exclusion criteria

  • neurological and/or neurosurgical disorders, anticholinergic-naive patients, bladder cancer, bladder stone, interstitial cystitis, prostate cancer chronic prostatitis bladder outlet obstruction

Trial design

60 participants in 1 patient group

singel
Treatment:
Procedure: Injection of onabotulinumtoxinA into the bladder wall

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems